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Abstract: Transfusion–acquired babesiosis can be an asymptomatic or self-limited febrile
hemolytic illness in a healthy host. A persistent, relapsing and/or fulminant course with
the development of life threatening complications may be seen in immunocompromised
or splenectomized patients. As in malaria, erythrocyte parasitemia is often associated
with non-immune hemolysis, and can be treated with erythrocytapheresis. Just as warm
autoantibodies have been reported in malaria infection, the development of autoantibodymediated immune hemolysis has been reported in babesiosis. We treated a previously
healthy male with multiple injuries from a motor vehicle accident necessitating massive
transfusion. His hospital course was complicated. Late in the hospitalization, his blood
smear revealed Babesia microti, confirmed by PCR study and serology.

Specific

antiobiotic therapy was begun, and severe hemolysis from a high parasite burden required
red blood cell exchange which led to rapid abatement of the hemolysis. He had a positive
DAT (IgG with a pan-reactive eluate) but no serum autoantibody. This persisted for 10
days following cessation of hemolysis, and became negative while still on antibiotics
while his parasite burden became undetectable. Reports of autoimmunity caused by
babesiosis often have severe hemolysis from their autoantibodies, but our case shows that
immune hemolysis from autoantibodies in babesiosis is not a constant finding. The nature
of the autoantigen is unknown.
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Introduction

Babesiosis is a zoonotic protozoan disease transmitted primarily by genus Ixodes ticks.
Babesia microti and Babesia divergens are the two most common species of babesia
infecting humans in the United States [1]. These parasites can infest erythrocytes and
cause malaria-like illness. There has been an increased awareness of transfusion-acquired
babesiosis (TAB) in the last two decades, with more than 50 cases reported since 1980
[2]. Several factors contribute to the risk of TAB transmission. Most donor infections are
asymptomatic, and currently there is no licensed donor screening assay for Babesia [3].
Tick borne pathogens can survive in refrigerated [4, 5] or frozen-thawed [6] blood
components.

Infections with Babesia can run a varied clinical course. Healthy hosts may have an
asymptomatic or self-limited febrile illness. Both adults and children who are immune
compromised or have undergone splenectomy are at risk to develop severe symptomatic
infections with malaise, myalgias, fever, chills and sweating. These patients may have a
chronic persistent, relapsing or fulminant course [1] and develop life threatening
complications, including acute respiratory distress syndrome [7], disseminated
intravascular coagulation and acute renal failure [8]. Human babesiosis is often
associated with non-immune hemolysis from the erythrocytic parasites, and occasionally
thrombocytopenia in more severe cases.
Many infections or inflammatory diseases may cause immune dysregulation; and
bacterial, viral and parasitic pathogens have been known to stimulate autoantibodies that
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crossreact with similar antigens on erythrocytes. Autoimmunity to red blood cells in
babesiosis has been documented in humans [9, 10] just as it has been reported in malaria
infection [11, 12, 13].

Case Report

A 61 year old, Group O, Rh negative male, with a negative antibody screen was in a
motor vehicle accident on August 5 in which he sustained multiple injuries including
cervical burst fracture at C7, multilevel thoracic spinal compression fractures, scapular
fracture, multiple rib fractures and severe intraabdominal injuries. During transport to our
facility he became hypotensive, and responded to pressors, fluid resuscitation and
emergency blood transfusion. Exploratory laparotomy revealed mesenteric hematoma,
hemoperitoneum, splenic laceration requiring splenectomy, and liver laceration. The
hemorrhage was controlled and while in the OR the patient underwent application of
cranial traction to treat his unstable cervical fracture. He received a total of 19 units of
packed red cells (12 Rh negative, 7 Rh positive), 2 Rh negative apheresis platelets, 18
units of FFP and 10 units of cryoprecipitate while he had active bleeding during his first
36 hours. Three days later (day +4), he returned to the OR for abdominal washout,
removal of packs, wound closure and placement of feeding gastrostomy tube and
required no transfusion. On day +6 he underwent anterior decompression and
stabilization of the cervical fracture requiring no blood intraoperatively, but 2 units of Rh
negative red cells were given in the post-op period. His hospital course and recovery
were complicated by multiple episodes of aspiration pneumonia, urosepsis and central
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line infection. He was treated with multiple antibiotics, including Zosyn, Ciprofloxacin,
Vancomycin and Tobramycin during this time.
Additional red blood cell transfusions were needed beginning on day +41 because of
worsening anemia. Compatibility testing revealed he had developed alloantibodies to D
and E but he did not have a positive DAT or evidence of a serum autoantibody. His Rh
typing was Group O, Rh negative with no mixed field appearance at that time. On day
+51, a weakly positive DAT for IgG was detected. An eluate (Elukit method) reacted
with all D-E- cells tested. The serum again did not demonstrate an autoantibody or
additional alloantibody. His LDH was 1052 U/L and reticulocyte count 9.3% (absolute
291,000 B/L). To evaluate whether he had a drug antibody, studies at a reference
laboratory demonstrated no reactivity using the two antibiotics he was still receiving
which have most commonly been implicated, Zosyn and Vancomycin.
Between day +41 and day +51, his hemoglobin dropped from 9.6 to 7.2 gm/dL despite
the transfusion of 3 units of Rh negative red blood cells and the reticulocyte count
remained elevated (absolute 292,000 B/L). The serum haptoglobin was <6 gm/dL and a
new serum alloantibody was detected, anti-C. The anti-C was not revealed in repeat
elution studies, although the DAT was still positive for a pan-reactive antibody.
On day +54, examination of his blood smear revealed numerous red cells with
intracellular parasites suggestive of Babesia microti, subsequently confirmed by PCR and
serology. Retrospectively, blood smears retrieved from the previous few days revealed
scattered B. microti infected RBCs that had been overlooked. The level of parasitemia on
day +54 was 7.8%. Treatment with Gentimycin and Azithromycin was initiated, but
hemolysis continued despite several days of antibiotic treatment. On hospital day +57, he
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had worsening symptomatic hemolytic anemia, with Hgb dropping to 5.6 gm/dL,
increasing reticulocytosis and symptomatic tachycardia, hypoxia and dyspnea. Red blood
cell exchange with 8 units of Rh negative red blood cells was performed with rapid
clinical improvement following the exchange transfusion. Evidence of hemolysis abated
rapidly. The exchange dramatically reduced the parasite burden to 0.6% by the next day
and to <0.003% on day +63. A blood smear on day +67, ten days after the exchange, was
clear of all parasites. The positive DAT for IgG persisted for 10 days following cessation
of his hemolysis and then became nondetectable. The patient continued to improve
clinically and was eventually discharged home after completing his course of antibiotics.
No further transfusion was required after the red cell exchange and his Hgb remained
stable. His elevated reticulocytes began declining after the exchange and returned to
normal within nine days.

Epidemiology

The patient was a retired state trooper who lived in central Pennsylvania. He denied a
history of known tick bites and his only exposure to fields or wooded areas was a round
of golf played a few weeks prior to his MVA. Given the usual 1-4 week incubation
period for community acquired babesiosis, TAB was suspected given its later
symptomatic onset. With the cooperation of our blood center, the infection was traced to
one of the donors of the units used during the massive transfusion on August 5. High titer
Babesia microti IgM antibody (IFA of 1:512) was found in a 4-month post-donation
sample. This donor lived in southern New Jersey, a known area of Babesia microti
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infestation. The PCR assay of the follow-up donor sample was negative and no residual
material from the original donation could be recovered. The case was reported as TAB
associated with the transfusion of red cells, most probably from the donor with high titer
IgM antibodies.

Discussion

The incubation period for TAB may be longer than after a tick bite [1], although the
delayed onset in our patient may also have been due to the antibiotics he had been on,
some of which had partial effectiveness against B. microti. The severity of TAB in our
patient can be attributed to his asplenic state, as has been reported, and may have become
more clinically apparent as his antibiotic therapies were completed.
Our patient’s positive DAT and apparent autoantibody could have been caused by
delayed transfusion reactions from anti-D, anti-E and anti-C induced by the Rh d
incompatible emergency transfusions on day 0 and day +1. However, the time course of
the serologic findings are much more compatible with this being TAB-associated
autoantibody. Our patient’s course of hemolysis was clearly different from the other
cases of TAB associated autoantibody reported in the literature.
In a series of cases, Wolf et al, [9] reported that three of 30 patients with clinical and
laboratory evidence of community acquired babesiosis, all asplenic, had positive DAT’s
due to IgG but not complement. Eluates prepared from the patients’ red blood cells
reacted with all cells but were markedly less reactive with Rh null cells. One of the
patients developed marked hemolysis with 8% Babesia microti parasitemia following
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travel to an endemic area. She was treated with red blood cell exchange and developed
anti-E and anti-c. She received multiple transfusions of antigen negative blood, but
continued to have hemolysis, despite low parasitemia (0.1%), and persistence of the
autoantibody. This patient’s continued immune hemolysis responded to treatment with
steroids.
The second report of babesiosis with autoantibodies was described by Evenson, et al,
[10]. A 47 year old transplant recipient who had been receiving immunosuppressive
therapy for 8 years probably acquired babesia from a tick bite during travel to an endemic
area. The patient was treated with antibiotics and red blood cell exchange and stabilized.
Hemolysis improved transiently, but a few weeks after being discharged from the
hospital he was readmitted with worsening parasitemia. The DAT was positive for IgG,
but not C3. Red blood cell exchange was performed for the second time and his immune
suppression therapy was changed. Over the next six weeks he had increasing paresitemia
and another two episodes of worsening hemolysis with a positive DAT for both IgG and
C3. He was treated with antibiotics and red blood cell and plasma exchanges. Hemolysis
appeared to be due primarily to autoantibody rather than parasite burden. When the
antibody was no longer detectable parasitemia increased from <1% to 8.2% but he had no
worsening of hemolysis. Continued treatment with Clindamycin, Atovaquone and
Quinidine alone led to a drop in parasitemia. After two more months no parasites were
detected in his red blood cells and the DAT was negative. This patient had persistent
parasitemia, and his autoantibody contributed to hemolysis over four months, but
disappeared before the eradication of infection.
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Our experience underscores that TAB may cause severe hemolysis which can be
dramatically improved by exchange erythrocytopheresis.

Our experience also

underscores that TAB may cause the development of autoantibodies just as in community
acquired babesiosis, but immune hemolysis is not a constant finding and the autoantibody
may be transient and clinically innocuous.
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